🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Paul Tudor Jones’s CLBT Holdings & Trades

First Buy
Q4 2023
Duration Held
9 Quarters
Largest Add
Q4 2023
+412,339 Shares
Current Position
72,081 Shares
$1.3 M Value

Paul Tudor Jones's CLBT Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 72,081 shares of Cellebrite DI Ltd. (CLBT) worth $1.3 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 9 quarters.

Based on 13F filings, Paul Tudor Jones has maintained a strategic position in CLBT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 153,623 shares. Largest reduction occurred in Q3 2025, reducing 453,815 shares.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's Cellebrite DI (CLBT) Holding Value Over Time

Track share changes against reported price movement

Quarterly Cellebrite DI (CLBT) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +72,081 New Buy 72,081 $18.03
Q3 2025 -453,815 Sold Out 0 $0.00
Q2 2025 -88,210 Reduce 16.27% 453,815 $16.00
Q1 2025 +5,903 Add 1.10% 542,025 $19.43
Q4 2024 +53,832 Add 11.16% 536,122 $22.03
Q3 2024 +6,490 Add 1.36% 482,290 $16.84
Q2 2024 -90,162 Reduce 15.93% 475,800 $11.95
Q1 2024 +153,623 Add 37.26% 565,962 $11.08
Q4 2023 +412,339 New Buy 412,339 $8.66

Paul Tudor Jones's Cellebrite DI Investment FAQs

Paul Tudor Jones first purchased Cellebrite DI Ltd. (CLBT) in Q4 2023, acquiring 412,339 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held Cellebrite DI Ltd. (CLBT) for 9 quarters since Q4 2023.

Paul Tudor Jones's largest addition to Cellebrite DI Ltd. (CLBT) was in Q4 2023, adding 412,339 shares worth $3.57 M.

According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 72,081 shares of Cellebrite DI Ltd. (CLBT), valued at approximately $1.3 M.

As of the Q4 2025 filing, Cellebrite DI Ltd. (CLBT) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in Cellebrite DI Ltd. (CLBT) was 565,962 shares, as reported at the end of Q1 2024.